Atorvastatin/fluvastatin/simvastatin

Atorvastatin/fluvastatin/simvastatin Reactions 1680, p62 - 2 Dec 2017 Muscle pain: case report A-56-year-old man developed muscle pain/complaints during treatment with atorvastatin, simvastatin and fluvastatin [routes, time to reactions onsets and outcomes not stated]. In March 2016, the man, with progressive angina pectoris (90% left anterior descending stenosis, one stent) presented to the clinic. He was started on treatment with atorvastatin 20 mg/day which induced muscle pain. Later on, atorvastatin treatment was switched to simvastatin 20 mg/day; however, he reported muscle complaints. His low density lipoprotein (LDL) cholesterol concentration was at 4.8 mmol/L (185 mg/dL), creatine kinase was at 3.52 mmol/L (normal range: less than 3.17) and lipoprotein (a) level was at 173 nmol/L, which prompted urgent lipid lowering drug therapy. Thus he was started on treatment with ezetimibe, which decreased LDL cholesterol to 3.6 mmol/L (138 mg/dL), without causing muscle pains. In order to achieve LDL cholesterol target value of 1.8 mmol/L (70 mg/dL) or better below 1.4 mmol/L (45 mg/dL), fluvastatin was started with a slow increase in the drug dose up to 60 mg/day; however, he developed non-severe muscle pain on fluvastatin treatment. His creatine kinase level was between 3.9 and 6.2 mmol/L, and LDL cholesterol was between 1.9 and 2.2 mmol/L (73-85 mg/dL). The man’s fluvastatin dose was decreased to 40 mg/day. As the target value for LDL cholesterol was not achieved, cholestyramine was administered and he was able to tolerate the drug at low dose. Author comment: "Statins have become an established option in lipid-lowering pharmacotherapy despite the fact that statin intolerance is fairly common. When muscle pains and/or an elevation of the creatine kinase appear, the dose must be lowered in patients with slight symptoms or stopped altogether if the symptoms are more severe." Fischer S, et al. Management of patients with statin intolerance. Atherosclerosis Supplements 30: 33-37, Nov 2017. Available from: URL: http://doi.org/10.1016/ j.atherosclerosissup.2017.05.013 - Germany 803284401 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Atorvastatin/fluvastatin/simvastatin

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/atorvastatin-fluvastatin-simvastatin-b8EGSj0W0x
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-38993-0
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p62 - 2 Dec 2017 Muscle pain: case report A-56-year-old man developed muscle pain/complaints during treatment with atorvastatin, simvastatin and fluvastatin [routes, time to reactions onsets and outcomes not stated]. In March 2016, the man, with progressive angina pectoris (90% left anterior descending stenosis, one stent) presented to the clinic. He was started on treatment with atorvastatin 20 mg/day which induced muscle pain. Later on, atorvastatin treatment was switched to simvastatin 20 mg/day; however, he reported muscle complaints. His low density lipoprotein (LDL) cholesterol concentration was at 4.8 mmol/L (185 mg/dL), creatine kinase was at 3.52 mmol/L (normal range: less than 3.17) and lipoprotein (a) level was at 173 nmol/L, which prompted urgent lipid lowering drug therapy. Thus he was started on treatment with ezetimibe, which decreased LDL cholesterol to 3.6 mmol/L (138 mg/dL), without causing muscle pains. In order to achieve LDL cholesterol target value of 1.8 mmol/L (70 mg/dL) or better below 1.4 mmol/L (45 mg/dL), fluvastatin was started with a slow increase in the drug dose up to 60 mg/day; however, he developed non-severe muscle pain on fluvastatin treatment. His creatine kinase level was between 3.9 and 6.2 mmol/L, and LDL cholesterol was between 1.9 and 2.2 mmol/L (73-85 mg/dL). The man’s fluvastatin dose was decreased to 40 mg/day. As the target value for LDL cholesterol was not achieved, cholestyramine was administered and he was able to tolerate the drug at low dose. Author comment: "Statins have become an established option in lipid-lowering pharmacotherapy despite the fact that statin intolerance is fairly common. When muscle pains and/or an elevation of the creatine kinase appear, the dose must be lowered in patients with slight symptoms or stopped altogether if the symptoms are more severe." Fischer S, et al. Management of patients with statin intolerance. Atherosclerosis Supplements 30: 33-37, Nov 2017. Available from: URL: http://doi.org/10.1016/ j.atherosclerosissup.2017.05.013 - Germany 803284401 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off